Free Newsletter
Stem cell therapy may replace liver transplants
Using mesenchymal stem cells taken from bone marrow, researchers at Massachusetts General Hospital have been able to spur the livers of rats to generate new tissue, raising the possibility that they can repair liver damage without resorting to a transplant--or buying more time for patients who would otherwise die waiting for a liver transplant. The liver is already known for its ability to regenerate, and lead scientist Dr Martin Yarmush says that they are easily able to gather enough bone marrow cells for the procedure.
The scientific team found that simply implanting the MSCs into the liver did not work. But they found that two other methods to deliver molecules secreted by the stem cells stopped cell death and lessened inflammation. In one group of rats, 71 percent treated with one of these processes survived, compared to 14 percent in the control group which survived a week.
- check out this release
- read the report from the BBC
Related Articles:
Stem cells used to regenerate liver tissue. Report
In breakthrough, mice produce human liver cells. Report
Stem cell researchers create tiny livers. Report
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




